Original article: https://jamanetwork.com/journals/jamapediatrics/fullarticle/2809315
Retraction notice: https://jamanetwork.com/journals/jamapediatrics/fullarticle/2822489
Article's conclusion —
Retraction following concerns raised —
Retraction notice: https://jamanetwork.com/journals/jamapediatrics/fullarticle/2822489
Article's conclusion —
The incidence of PCC in this study was strikingly low (0.4%). Most children experienced a resolution of symptoms within 2 weeks of infection. Pre–COVID-19 symptoms were factors in post–COVID-19 symptoms.
Retraction following concerns raised —
We identified a coding error whereby children with missing symptoms data were coded as having no symptoms. This error resulted in 2 participants being misclassified as having symptom resolution when they should have been classified as having PCC. We identified another child who should have been classified as having PCC.
We also identified an error in which we included only participants with at least 2 months of symptom data (coded as 61 days) rather than those with at least 8 weeks (56 days) of symptom data. This difference resulted in the exclusion of 15 participants who should have been included in the analysis. In addition, we originally reported a study sample of children between 8 and 13 years of age. We subsequently identified participants with COVID-19 (cases) who were recruited between 1 and 7.49 years and 14.5 and 19 years of age. These participants were included in the original PCC analysis.
We had concluded that the incidence of PCC was 0.4% (1/271). In correcting these errors, we found that the incidence of PCC was 1.4% (4/286).